Uvox Tablet contains fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) primarily used to treat obsessive-compulsive disorder (OCD) and major depressive disorder. It may also be prescribed off-label for anxiety disorders such as social anxiety disorder and post-traumatic stress disorder (PTSD). For more information, visit Mayo Clinic, Drugs.com, FDA, WebMD, PubMed, Healthline, WHO, or MedlinePlus.

Key Benefits & Uses:

• Effective Treatment for OCD: Fluvoxamine helps manage symptoms of obsessive-compulsive disorder. See more at Mayo Clinic.

• Management of Major Depressive Disorder: It alleviates symptoms of depression, improving mood and overall well-being. Details at Drugs.com.

• Off-Label Use for Anxiety Disorders: Fluvoxamine may treat social anxiety disorder or PTSD. Learn more at Healthline.

• Potential Role in COVID-19 Treatment: Some studies suggest fluvoxamine may reduce the risk of severe COVID-19. Explore research at PubMed.

How to Use:
Take Uvox Tablet exactly as prescribed by your healthcare provider. The typical starting dose for OCD is 50 mg once daily, gradually increasing to a maximum of 300 mg per day depending on individual response. Always check detailed dosing guidelines on WebMD or MedlinePlus.

Important Safety Information:

• Suicidal Thoughts: Fluvoxamine may increase suicidal thoughts in children, teenagers, or young adults, especially during initial months or dose changes. Learn more at Healthline.

• Drug Interactions: Avoid taking fluvoxamine with MAO inhibitors or specific medications. Details at Mayo Clinic and FDA.

• Pregnancy and Breastfeeding: Consult your doctor before use during pregnancy or breastfeeding. Reference Drugs.com.

Common Side Effects:
Common side effects include nausea, vomiting, diarrhea, insomnia, somnolence, sexual dysfunction, headache, dizziness, and sweating. For more information, visit WebMD, PubMed, or Healthline.

Why Choose Uvox Tablet:
Uvox Tablet offers effective treatment for OCD and major depressive disorder, with potential benefits for anxiety disorders. Fluvoxamine’s unique action on serotonin and sigma-1 receptors may contribute to its efficacy. Learn more at WHO and MedlinePlus.